BLRX · BioLineRx Ltd.
Market Cap
$12.23M
Shares
4.37M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$1.18M
-95.9%
FY2025
Net Income
-$2.03M
+78%
FY2025
Gross Margin
80.51%
+12.5pp
FY2025
Operating Margin
-871.78%
-801.3pp
FY2025
Diluted EPS
$0.00
+100%
FY2025
Operating Cash Flow
-$8.07M
+81.6%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| $1.18M | $28.94M | $4.8M | $0 | $0 | — | — | — | — | — | — | |
| $230K | $9.26M | $3.69M | $0 | $0 | — | — | — | — | — | — | |
| $950K | $19.68M | $1.11M | $0 | $0 | — | — | — | — | — | — | |
| 80.51% | 67.99% | 23.08% | — | — | — | — | — | — | — | — | |
| $8.09M | $9.15M | $12.52M | $17.63M | $19.47M | $18.17M | $23.44M | $19.81M | $19.51M | $11.18M | $11.49M | |
| $0 | $23.61M | $25.27M | $6.46M | $1M | $840K | $857K | $1.36M | $1.69M | $1.35M | $1M | |
| $495K | $431K | $583K | $615K | $660K | $864K | $862K | $424K | $452K | $452K | $414K | |
| -$10.29M | -$20.41M | -$49.69M | -$29.16M | -$24.78M | -$22.93M | -$28.11M | -$25.61M | -$25.24M | -$16.51M | -$16.2M | |
| -871.78% | -70.52% | -1035.29% | — | — | — | — | — | — | — | — | |
| -$9.79M | -$19.98M | -$49.11M | -$28.54M | -$24.12M | -$22.06M | -$27.25M | -$25.18M | -$24.79M | -$16.06M | -$15.78M | |
| $1.28M | $9.12M | $2.17M | $2.16M | $1.01M | $1.63M | $2.28M | $473K | $21K | $22K | $106K | |
| $0 | $0 | $0 | $0 | $0 | $0 | $0 | — | — | — | — | |
| -$2.03M | -$9.22M | -$60.61M | -$24.95M | -$27.05M | -$30.02M | -$25.45M | -$22.96M | -$24.35M | -$15.84M | -$14.4M | |
| -171.69% | -31.86% | -1262.79% | — | — | — | — | — | — | — | — | |
| USD/shares | $0.00 | -$0.01 | -$0.06 | -$0.03 | -$1.60 | -$4.80 | — | — | — | — | — |
| USD/shares | $0.00 | -$0.01 | -$0.06 | -$0.03 | -$1.60 | -$4.80 | — | — | — | — | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Key facts
CIK
1498403
CUSIP
09071M304
13F (30d)
12 filings
12 filers
Visit website
Investor relations